• Resize Text
    • Small Text
    • Medium Text
    • Large Text
    • Connect

ISO 14001 accreditation

Rosemont Pharmaceuticals has recently successfully completed an audit focused on its management system’s adherence to the ISO 14001:2015 Standards.

The ISO 14001 is an internationally recognised framework that allows businesses to address the concerns of climate change, biodiversity loss and resource depletion. It comes from an understanding that businesses have a responsibility for these environmental issues and to ensure they’re working proactively to combat them. It’s a testament to the company’s commitment to a sustainable future.

The British Standards Institution conducted their audit of the liquid pharmaceutical manufacturer’s Environmental Management System (EMS) on the 2nd of April 2024 and found all the audit objectives were met including adherence to ISO 140001:2015 standards, compliance with regulatory requirements, and effective support for organisational objectives, as well as identifying areas for continuous improvement.

The audit conclusion underscores the efficacy of Rosemont’s management system in achieving its intended outcomes and confirms Rosemont’s unwavering dedication to excellence and commitment to upholding the highest standards of environmental responsibility while playing a pivotal role in its continued success.

ROS000081-002 DOP May 2024